Recombinant APP (Donanemab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects APP (Donanemab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.
Catalog No. ABIN7488202
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant APP (Donanemab Biosimilar) antibody (ABIN7488202)
Target
APP (Donanemab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This APP (Donanemab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Donanemab Biosimilar - Anti-APP mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- APP (Donanemab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
LY3002813
Donanemab is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research.
Target
-
You are here:
